Allogene Therapeutics, Inc.ALLONASDAQ
Loading
Income Before Tax Over TimeExpanding
Percentile Rank63
Studio
Year-over-Year Change

Pre-tax earnings

Latest
$-190.89M
↑ 12% vs avg
Percentile
P63
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-216.06M
Historical baseline
PeriodValueYoY Change
TTM$-190.89M+25.8%
2024$-257.15M+21.4%
2023$-327.26M+3.9%
2022$-340.41M-87.0%
2021$-182.05M+27.2%
2020$-250.22M-35.3%
2019$-184.93M+12.6%
2018$-211.62M-881658.3%
2017$-24000.00-